13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001536562
Total reported value
$49.2M
$49.2M
32 檔
59.2%
According to the latest 13F quarterly dataset, JGP Global Gestao de Recursos Ltda. managed an equity portfolio of $49.2M at the end of Q2 2026, spanning 32 distinct U.S. exchange-listed positions.
JGP Global Gestao de Recursos Ltda. executed strategic sector rebalancing during Q2 2026, establishing 17 new positions while fully exiting 11 holdings and trimming 7 positions.
In terms of portfolio concentration, the top 5 core holdings (including XPEV, SPY, SFTBY) accounted for 59.2% of total reported equity market value during Q2 2026.
Top New Position Initiated
SPY
市值: $7.7M
Top Position Liquidated / Trimmed
STNE
前期市值: $6.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XPEV | XPeng Inc. | Stock-Other | 23.60% | +5.42% | +153.36% | |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 16.95% | -0.99% | — | |
| 3 | SFTBY | Softbank Group Corp-unsp Adr | Stock-Other | 9.38% | -9.38% | EXIT | |
| 4 | VEON | Veon LTD | Stock-Other | 7.69% | -7.69% | EXIT | |
| 5 | PROSY | Prosus NV -spon Adr | Stock-Other | 6.57% | +8.44% | — | |
| 6 | ATAI | Ataibeckley Inc | Stock-Other | 5.81% | -5.81% | EXIT | |
| 7 | ECHO | Echostar Corp-a | Stock-Comm Services | 4.84% | -4.84% | EXIT | |
| 8 | CKHUY | Ck Hutchison Holdin-unsp Adr | Stock-Other | 3.36% | -3.36% | EXIT | |
| 9 | ITUB | Itau Unibanco H-spon Prf Adr | Stock-Financials | 3.02% | -3.02% | EXIT | |
| 10 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.91% | -0.25% | -10.80% | |
| 11 | ABBV | Abbvie Inc | Stock-Healthcare | 1.59% | -0.02% | -6.51% | |
| 12 | INCY | Incyte CORP | Stock-Healthcare | 1.41% | -0.02% | — | |
| 13 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.33% | -0.02% | +11.07% | |
| 14 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.14% | -0.19% | — | |
| 15 | ONC | Beone Medicines Ltd-adr | Stock-Other | 1.08% | +0.19% | — | |
| 16 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.96% | +0.07% | — | |
| 17 | STM | Stmicroelectronics Nv-ny Shs | Stock-Tech | 0.88% | -0.88% | EXIT | |
| 18 | NVDA | Nvidia CORP | Stock-Tech | 0.82% | +1.72% | +97.50% | |
| 19 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.79% | — | +35.01% | |
| 20 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.78% | +0.02% | -0.11% | |
| 21 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 0.73% | +0.01% | — | |
| 22 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.60% | +0.07% | -8.28% | |
| 23 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.59% | +0.16% | -24.15% | |
| 24 | ABT | Abbott Laboratories | Stock-Healthcare | 0.58% | +0.01% | -7.11% | |
| 25 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.51% | -0.07% | — | |
| 26 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.50% | -0.02% | -24.53% | |
| 27 | SYK | Stryker CORP | Stock-Healthcare | 0.48% | -0.48% | EXIT | |
| 28 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.45% | -0.45% | EXIT | |
| 29 | ALB | Albemarle CORP | Stock-Materials | 0.30% | -0.30% | EXIT | |
| 30 | PONY | Pony Ai Inc | Stock-Other | 0.28% | -0.28% | EXIT | |
| 31 | BIDU | Baidu Inc - Spon Adr | Stock-Comm Services | 0.04% | -0.04% | EXIT | |
| 32 | OIBR-USD | Oi Sa-adr | Stock-Other | 0.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +17% | NEW | New buy |
| 2 | SFTBY | Softbank Group Corp-unsp Adr | +9.4% | NEW | New buy |
| 3 | VEON | Veon LTD | +7.7% | NEW | New buy |
| 4 | PROSY | Prosus NV -spon Adr | +6.6% | NEW | New buy |
| 5 | ATAI | Ataibeckley Inc | +5.8% | NEW | New buy |
| 6 | ECHO | Echostar Corp-a | +4.8% | NEW | New buy |
| 7 | CKHUY | Ck Hutchison Holdin-unsp Adr | +3.4% | NEW | New buy |
| 8 | ITUB | Itau Unibanco H-spon Prf Adr | +3% | NEW | New buy |
| 9 | XPEV | XPeng Inc. | +2.3% | +153.36% | Add |
| 10 | UNH | Unitedhealth Group Inc | +1.1% | NEW | New buy |
| 11 | MRK | Merck & Co. Inc. | +1% | NEW | New buy |
| 12 | STM | Stmicroelectronics Nv-ny Shs | +0.9% | NEW | New buy |
| 13 | RVMD | Revolution Medicines Inc | +0.7% | NEW | New buy |
| 14 | SYK | Stryker CORP | +0.5% | NEW | New buy |
| 15 | ACAD | Acadia Pharmaceuticals Inc | +0.5% | NEW | New buy |
| 16 | ALB | Albemarle CORP | +0.3% | NEW | New buy |
| 17 | PONY | Pony Ai Inc | +0.3% | NEW | New buy |
| 18 | BIDU | Baidu Inc - Spon Adr | 0% | NEW | New buy |
| 19 | OIBR-USD | Oi Sa-adr | 0% | — | Unchanged |
| 20 | ARM | Arm Holdings Plc-adr | -0.1% | EXIT | Sold out |
| 21 | EEM | Ishares Msci Emerging Market | -0.1% | EXIT | Sold out |
| 22 | VRTX | Vertex Pharmaceuticals Inc | -0.3% | +35.01% | Add |
| 23 | NVDA | Nvidia CORP | -0.3% | +97.50% | Add |
| 24 | MDGL | Madrigal Pharmaceuticals Inc | -0.5% | — | Unchanged |
| 25 | ABT | Abbott Laboratories | -0.8% | -7.11% | Trim |
| 26 | GILD | Gilead Sciences Inc | -0.8% | -8.28% | Trim |
| 27 | BMY | Bristol-myers Squibb Co | -0.8% | -0.11% | Trim |
| 28 | INCY | Incyte CORP | -0.9% | — | Unchanged |
| 29 | BSX | Boston Scientific CORP | -0.9% | EXIT | Sold out |
| 30 | VNET | Vnet Group Inc-adr | -0.9% | EXIT | Sold out |
| 31 | TMO | Thermo Fisher Scientific Inc | -0.9% | -24.15% | Trim |
| 32 | ZTS | Zoetis Inc | -0.9% | EXIT | Sold out |
| 33 | INSM | Insmed Inc | -0.9% | EXIT | Sold out |
| 34 | JNJ | Johnson & Johnson | -0.9% | +11.07% | Add |
| 35 | ISRG | Intuitive Surgical Inc | -1% | -24.53% | Trim |
| 36 | MCK | Mckesson CORP | -1.1% | EXIT | Sold out |
| 37 | ONC | Beone Medicines Ltd-adr | -1.1% | — | Unchanged |
| 38 | ABBV | Abbvie Inc | -1.3% | -6.51% | Trim |
| 39 | TSM | Taiwan Semiconductor-sp Adr | -1.5% | EXIT | Sold out |
| 40 | LLY | Eli Lilly & Co | -2% | -10.80% | Trim |
| 41 | SOLS | Solstice Adv Materials Inc | -3.3% | EXIT | Sold out |
| 42 | NU | Nu Holdings Ltd. | -14.6% | EXIT | Sold out |
| 43 | STNE | StoneCo Ltd. | -29.3% | EXIT | Sold out |
According to official SEC Form 13F filings, JGP Global Gestao de Recursos Ltda. reported a total U.S. public equity portfolio value of $49.2M across 32 disclosed positions in Q2 2026.
During Q2 2026, JGP Global Gestao de Recursos Ltda.'s top holdings by market value included XPEV (23.6%)、SPY (16.9%)、SFTBY (9.4%). The largest single position, XPEV, represented 23.6% of total portfolio value.
In Q2 2026, JGP Global Gestao de Recursos Ltda. made 39 total portfolio adjustments, initiating 17 new buys, adding to 4 positions, trimming 7 holdings, and fully liquidating 11 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.